| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |